Yubo Biotech Total Assets 2012-2025 | YBGJ
Yubo Biotech total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
|
Yubo Biotech Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $2 |
| 2023 | $2 |
| 2022 | $2 |
| 2021 | $5 |
| 2020 | $2 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
|
Yubo Biotech Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-09-30 | $1 |
| 2025-06-30 | $1 |
| 2025-03-31 | $1 |
| 2024-12-31 | $2 |
| 2024-09-30 | $2 |
| 2024-06-30 | $2 |
| 2024-03-31 | $2 |
| 2023-12-31 | $2 |
| 2023-09-30 | $2 |
| 2023-06-30 | $2 |
| 2023-03-31 | $2 |
| 2022-12-31 | $2 |
| 2022-09-30 | $4 |
| 2022-06-30 | $4 |
| 2022-03-31 | $4 |
| 2021-12-31 | $5 |
| 2021-09-30 | $4 |
| 2021-06-30 | $4 |
| 2021-03-31 | $4 |
| 2020-12-31 | $2 |
| 2020-11-30 | $0 |
| 2020-09-30 | $0 |
| 2020-08-31 | $0 |
| 2020-06-30 | $0 |
| 2020-05-31 | $0 |
| 2020-03-31 | $0 |
| 2020-02-29 | $0 |
| 2019-11-30 | $0 |
| 2019-08-31 | $0 |
| 2019-05-31 | $0 |
| 2019-02-28 | $0 |
| 2018-11-30 | $0 |
| 2018-08-31 | $0 |
| 2018-05-31 | $0 |
| 2018-02-28 | $0 |
| 2017-11-30 | $0 |
| 2017-08-31 | $0 |
| 2017-05-31 | $0 |
| 2017-02-28 | $0 |
| 2016-11-30 | $0 |
| 2016-08-31 | $0 |
| 2016-05-31 | $0 |
| 2016-02-29 | $0 |
| 2015-11-30 | $0 |
| 2015-08-31 | $0 |
| 2015-05-31 | $0 |
| 2015-02-28 | $0 |
| 2014-11-30 | $0 |
| 2014-08-31 | $0 |
| 2014-05-31 | $0 |
| 2014-02-28 | $0 |
| 2013-11-30 | $0 |
| 2013-08-31 | $0 |
| 2013-05-31 | $0 |
| 2013-02-28 | $0 |
| 2012-11-30 | $0 |
| 2012-08-31 | $0 |
| 2012-05-31 | $0 |
| 2012-02-29 | $0 |
| 2011-11-30 | $0 |
| 2011-08-31 | $0 |
| 2011-05-31 | $0 |
| 2011-02-28 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.002B | $0.000B |
| MAGNA-LAB INC. is a development stage company. Co. has developed and now markets and intends to produce the MAGNA-SLn, the first of Co.'s proposed series of anatomy specific MRI (Magnetic Resonance Imaging) products which are smaller and cost less to own, install and operate than present ``whole body`` MRI systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $235.186B | 27.95 |
| Intuitive Surgical (ISRG) | United States | $187.838B | 71.78 |
| IDEXX Laboratories (IDXX) | United States | $55.405B | 55.02 |
| Edwards Lifesciences (EW) | United States | $48.548B | 32.55 |
| IQVIA Holdings (IQV) | United States | $40.073B | 22.35 |
| Alcon (ALC) | Switzerland | $39.713B | 26.76 |
| Mettler-Toledo (MTD) | United States | $28.729B | 33.61 |
| DexCom (DXCM) | United States | $28.417B | 39.17 |
| STERIS (STE) | Ireland | $25.471B | 26.29 |
| Waters (WAT) | United States | $23.361B | 30.89 |
| Coloplast (CLPBY) | Denmark | $19.201B | 32.77 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.786B | 0.00 |
| Hologic (HOLX) | United States | $16.729B | 17.58 |
| Penumbra (PEN) | United States | $14.069B | 98.97 |
| Globus Medical (GMED) | United States | $12.383B | 25.99 |
| Masimo (MASI) | United States | $7.598B | 24.35 |
| Glaukos (GKOS) | United States | $6.891B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.232B | 19.80 |
| TransMedics (TMDX) | United States | $4.624B | 54.78 |
| Teleflex (TFX) | United States | $4.570B | 7.28 |
| LivaNova (LIVN) | United Kingdom | $3.449B | 18.63 |
| Veracyte (VCYT) | United States | $3.341B | 38.08 |
| Integer Holdings (ITGR) | United States | $3.021B | 14.18 |
| Elekta AB (EKTAY) | Sweden | $2.486B | 23.26 |
| Alphatec Holdings (ATEC) | United States | $2.320B | 0.00 |
| Artivion (AORT) | United States | $2.038B | 93.52 |
| Nihon Kohden (NHNKY) | Japan | $2.026B | 17.69 |
| UFP Technologies (UFPT) | United States | $1.995B | 26.34 |
| PROCEPT BioRobotics (PRCT) | United States | $1.628B | 0.00 |
| AxoGen (AXGN) | United States | $1.514B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.349B | 0.00 |
| IRadimed (IRMD) | United States | $1.283B | 61.13 |
| Pulse Biosciences (PLSE) | United States | $1.023B | 0.00 |
| OPKO Health (OPK) | United States | $1.013B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.927B | 5.02 |
| Pacific Biosciences Of California (PACB) | United States | $0.779B | 0.00 |
| SiBone (SIBN) | United States | $0.729B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.703B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.647B | 37.64 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.608B | 12.12 |
| Alpha Tau Medical (DRTS) | Israel | $0.593B | 0.00 |
| NeuroPace (NPCE) | United States | $0.557B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.528B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.456B | 12.60 |
| OrthoPediatrics (KIDS) | United States | $0.454B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.446B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.428B | 0.00 |
| RxSight (RXST) | United States | $0.391B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.372B | 61.94 |
| Sight Sciences (SGHT) | United States | $0.318B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.287B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.266B | 0.00 |
| 908 Devices (MASS) | United States | $0.248B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.192B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.164B | 0.00 |
| Inogen (INGN) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Neuronetics (STIM) | United States | $0.146B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.140B | 0.00 |
| Solana (HSDT) | United States | $0.140B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.133B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.129B | 0.00 |
| Hyperfine (HYPR) | United States | $0.120B | 0.00 |
| Accuray (ARAY) | United States | $0.092B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.083B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.027B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.59 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |